Besides, the expression of FBN2 is gradually downregulated from normal to the metastatic tumor, indicating that the downregulation of this gene is associated with tumor progression (Welch’s t-test, p < 0.05) (Figure 7). The gene discussed is FBN2; the disease is neoplasm.